Search
for
Sort by
Research 691–720 of 1000+
- 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
- Topical metformin as a novel therapy for alopecia areata due to its immunologic effects
- Survey of pediatric dermatologist views on treatment for alopecia areata
- Treatment of androgenetic alopecia by exosomes secreted from hair papilla cells and the intervention effect of LTF
- Treatment modalities for lymphocytic and neutrophilic scarring alopecia
- Androgenetic alopecia: An update
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- An Overview about Alopecia Areata Etiopathogenesis, Diagnosis, and Management: Review Article
- Logic-Based Modeling and Drug Repurposing for the Prediction of Novel Therapeutic Targets and Combination Regimens against E2F1-Driven Melanoma Progression
- Skin Biology and Ageing
- P64 Efficacy of baricitinib in patients with different degrees of severe alopecia areata: 52-week results from BRAVE-AA1 and BRAVE-AA2
- Systemic immunotherapies
- ISID1108 - Comparison of ruxolitinib and a collagen-targeted PTH-based hair cycle stimulant on hair follicle counts and hair growth in the C3H/HeJ engrafted mouse model of alopecia areata.
- ISID1394 - Long non-coding RNA AL136131.3 inhibits hair growth through mediating glycolysis in androgenetic alopecia
- A Promising Efficacy of Tofacitinib in an Adult Patient with Alopecia Areata
- Tofacitinib: A Promising Treatment for Adolescent Alopecia Areata
- Review of efficacy of baricitinib in the treatment of alopecia areata
- 504 A single-center retrospective study evaluating the efficacy of intravenous methylprednisolone pulse therapy for 113 patients with alopecia areata
- 1372 Modulation of YBX1 phosphorylation determines epidermal stem cell function
- Baricitinib for alopecia areata
- Pattern hair loss distribution: a novel presentation for alopecia areata
- Analyzing the role of tofacitinib in treatment of alopecia areata: A retrospective analysis from a tertiary care center of North India
- Alopecia areata in children: an overview of clinical features and recent treatment options
- 013 IL-15/IL-15Rα signaling is a guardian of human hair follicle immune privilege and promotes hair growth
- The usefulness and wellbeing of Tofacitinib in the treatment of Alopecia Areata
- 32237 Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2
- Common Causes of Hair Loss
- P100: Efficacy of current treatments under study in patients with alopecia areata
- EE325 Budget Impact of Baricitinib for Patients with Severe Alopecia Areata
- <i>JAMA Dermatology—</i>The Year in Review, 2021